nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—HTR4—adrenal cortex—polycystic ovary syndrome	0.0257	0.0968	CbGeAlD
Cisapride—HTR4—pituitary gland—polycystic ovary syndrome	0.0208	0.0782	CbGeAlD
Cisapride—HTR4—adrenal gland—polycystic ovary syndrome	0.0186	0.0699	CbGeAlD
Cisapride—CYP2C19—urine—polycystic ovary syndrome	0.0166	0.0624	CbGeAlD
Cisapride—CYP1A2—urine—polycystic ovary syndrome	0.0135	0.0509	CbGeAlD
Cisapride—CYP2C9—urine—polycystic ovary syndrome	0.0128	0.0483	CbGeAlD
Cisapride—HTR2A—urine—polycystic ovary syndrome	0.0106	0.0398	CbGeAlD
Cisapride—Metoclopramide—CYP17A1—polycystic ovary syndrome	0.0101	0.497	CrCbGaD
Cisapride—CYP3A4—urine—polycystic ovary syndrome	0.0098	0.0369	CbGeAlD
Cisapride—CYP2D6—urine—polycystic ovary syndrome	0.00964	0.0363	CbGeAlD
Cisapride—Iloperidone—ADRA1A—polycystic ovary syndrome	0.00746	0.368	CrCbGaD
Cisapride—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00615	0.0231	CbGeAlD
Cisapride—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00549	0.0207	CbGeAlD
Cisapride—HTR2B—adrenal cortex—polycystic ovary syndrome	0.00525	0.0198	CbGeAlD
Cisapride—HTR2B—endometrium—polycystic ovary syndrome	0.00469	0.0176	CbGeAlD
Cisapride—CYP2A6—vagina—polycystic ovary syndrome	0.00457	0.0172	CbGeAlD
Cisapride—HTR2B—uterus—polycystic ovary syndrome	0.00432	0.0163	CbGeAlD
Cisapride—HTR2B—adipose tissue—polycystic ovary syndrome	0.00423	0.0159	CbGeAlD
Cisapride—HTR2B—adrenal gland—polycystic ovary syndrome	0.00379	0.0143	CbGeAlD
Cisapride—KCNH2—endometrium—polycystic ovary syndrome	0.00374	0.0141	CbGeAlD
Cisapride—HTR2B—vagina—polycystic ovary syndrome	0.00351	0.0132	CbGeAlD
Cisapride—KCNH2—uterus—polycystic ovary syndrome	0.00345	0.013	CbGeAlD
Cisapride—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00344	0.0129	CbGeAlD
Cisapride—DRD2—pituitary gland—polycystic ovary syndrome	0.00343	0.0129	CbGeAlD
Cisapride—CYP2C8—endometrium—polycystic ovary syndrome	0.00342	0.0129	CbGeAlD
Cisapride—HTR2A—embryo—polycystic ovary syndrome	0.00342	0.0129	CbGeAlD
Cisapride—KCNH2—pituitary gland—polycystic ovary syndrome	0.00338	0.0127	CbGeAlD
Cisapride—CYP2C8—pituitary gland—polycystic ovary syndrome	0.0031	0.0116	CbGeAlD
Cisapride—KCNH2—adrenal gland—polycystic ovary syndrome	0.00302	0.0114	CbGeAlD
Cisapride—CYP2C19—vagina—polycystic ovary syndrome	0.00294	0.0111	CbGeAlD
Cisapride—KCNH2—female gonad—polycystic ovary syndrome	0.00282	0.0106	CbGeAlD
Cisapride—KCNH2—vagina—polycystic ovary syndrome	0.0028	0.0105	CbGeAlD
Cisapride—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00278	0.0105	CbGeAlD
Cisapride—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00275	0.0103	CbGeAlD
Cisapride—Gefitinib—CYP1A1—polycystic ovary syndrome	0.00274	0.135	CrCbGaD
Cisapride—DRD2—endocrine gland—polycystic ovary syndrome	0.00266	0.01	CbGeAlD
Cisapride—KCNH2—endocrine gland—polycystic ovary syndrome	0.00262	0.00986	CbGeAlD
Cisapride—CYP2C8—vagina—polycystic ovary syndrome	0.00256	0.00965	CbGeAlD
Cisapride—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00248	0.00934	CbGeAlD
Cisapride—CYP2C8—endocrine gland—polycystic ovary syndrome	0.0024	0.00902	CbGeAlD
Cisapride—CYP3A5—female gonad—polycystic ovary syndrome	0.00233	0.00876	CbGeAlD
Cisapride—CYP3A5—vagina—polycystic ovary syndrome	0.00231	0.00871	CbGeAlD
Cisapride—CYP2B6—vagina—polycystic ovary syndrome	0.0023	0.00865	CbGeAlD
Cisapride—HTR2A—pituitary gland—polycystic ovary syndrome	0.00227	0.00852	CbGeAlD
Cisapride—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00224	0.00845	CbGeAlD
Cisapride—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00217	0.00815	CbGeAlD
Cisapride—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00215	0.0081	CbGeAlD
Cisapride—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00213	0.00802	CbGeAlD
Cisapride—HTR2A—adrenal gland—polycystic ovary syndrome	0.00202	0.00761	CbGeAlD
Cisapride—HTR2A—vagina—polycystic ovary syndrome	0.00188	0.00706	CbGeAlD
Cisapride—HTR2A—endocrine gland—polycystic ovary syndrome	0.00176	0.0066	CbGeAlD
Cisapride—CYP2D6—female gonad—polycystic ovary syndrome	0.00172	0.00647	CbGeAlD
Cisapride—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00162	0.00611	CbGeAlD
Cisapride—CYP2D6—endocrine gland—polycystic ovary syndrome	0.0016	0.00602	CbGeAlD
Cisapride—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	5.7e-05	7.99e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	5.66e-05	7.93e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	5.65e-05	7.92e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.64e-05	7.9e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.61e-05	7.86e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.61e-05	7.85e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	5.6e-05	7.85e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	5.57e-05	7.81e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	5.53e-05	7.74e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	5.51e-05	7.71e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.5e-05	7.7e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.48e-05	7.67e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.39e-05	7.56e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	5.38e-05	7.54e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.36e-05	7.5e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	5.35e-05	7.5e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	5.35e-05	7.5e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	5.35e-05	7.5e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.35e-05	7.49e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	5.34e-05	7.48e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	5.31e-05	7.44e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	5.31e-05	7.44e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.31e-05	7.43e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	5.3e-05	7.43e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	5.29e-05	7.41e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.28e-05	7.39e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.27e-05	7.38e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	5.27e-05	7.38e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	5.27e-05	7.38e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	5.25e-05	7.36e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.19e-05	7.27e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	5.19e-05	7.26e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.16e-05	7.22e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	5.11e-05	7.16e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	5.1e-05	7.15e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.1e-05	7.14e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.07e-05	7.1e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—TH—polycystic ovary syndrome	5.05e-05	7.07e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	5.03e-05	7.05e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	5.02e-05	7.04e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	5.02e-05	7.03e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.02e-05	7.03e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	5e-05	7e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5e-05	7e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.98e-05	6.97e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	4.96e-05	6.94e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	4.94e-05	6.92e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—TH—polycystic ovary syndrome	4.94e-05	6.91e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	4.93e-05	6.9e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.92e-05	6.89e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	4.91e-05	6.88e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.9e-05	6.86e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	4.88e-05	6.84e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	4.88e-05	6.83e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	4.87e-05	6.82e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	4.8e-05	6.73e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	4.8e-05	6.73e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	4.79e-05	6.71e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.78e-05	6.69e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	4.77e-05	6.68e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.77e-05	6.68e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	4.74e-05	6.64e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.73e-05	6.62e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	4.71e-05	6.6e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.71e-05	6.6e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	4.69e-05	6.57e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.68e-05	6.56e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	4.68e-05	6.56e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	4.67e-05	6.54e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	4.65e-05	6.52e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	4.64e-05	6.49e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.62e-05	6.47e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	4.62e-05	6.47e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	4.61e-05	6.46e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	4.61e-05	6.45e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	4.6e-05	6.44e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	4.59e-05	6.43e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.56e-05	6.39e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.53e-05	6.35e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	4.52e-05	6.33e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.51e-05	6.32e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.5e-05	6.3e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.48e-05	6.27e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.43e-05	6.21e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.43e-05	6.2e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.43e-05	6.2e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	4.42e-05	6.19e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.41e-05	6.18e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.38e-05	6.13e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	4.36e-05	6.11e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.36e-05	6.1e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.35e-05	6.1e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	4.35e-05	6.1e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.33e-05	6.06e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	4.3e-05	6.03e-05	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IL6—polycystic ovary syndrome	4.3e-05	6.02e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.29e-05	6.02e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—TH—polycystic ovary syndrome	4.28e-05	5.99e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.25e-05	5.95e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.17e-05	5.84e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	4.16e-05	5.83e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	4.12e-05	5.77e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	4.12e-05	5.77e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	4.11e-05	5.75e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.08e-05	5.72e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.06e-05	5.68e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.05e-05	5.68e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	4.04e-05	5.66e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.04e-05	5.66e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.03e-05	5.65e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.03e-05	5.64e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.02e-05	5.63e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	3.93e-05	5.5e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.91e-05	5.48e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	3.91e-05	5.48e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	3.9e-05	5.46e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	3.88e-05	5.44e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	3.86e-05	5.41e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.85e-05	5.39e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	3.84e-05	5.38e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	3.84e-05	5.38e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—TH—polycystic ovary syndrome	3.82e-05	5.35e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	3.81e-05	5.33e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	3.78e-05	5.29e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	3.75e-05	5.26e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	3.74e-05	5.24e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.74e-05	5.23e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.73e-05	5.23e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—INS—polycystic ovary syndrome	3.73e-05	5.23e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	3.73e-05	5.22e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	3.72e-05	5.21e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.72e-05	5.21e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.71e-05	5.2e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.7e-05	5.18e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.7e-05	5.18e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.67e-05	5.14e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	3.65e-05	5.11e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.64e-05	5.1e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.61e-05	5.06e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.55e-05	4.97e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—TH—polycystic ovary syndrome	3.51e-05	4.92e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.5e-05	4.9e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.49e-05	4.89e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.49e-05	4.89e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	3.49e-05	4.89e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	3.49e-05	4.89e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.48e-05	4.87e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	3.47e-05	4.86e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	3.44e-05	4.82e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.44e-05	4.81e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—INS—polycystic ovary syndrome	3.42e-05	4.79e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.41e-05	4.78e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.39e-05	4.75e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.38e-05	4.74e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	3.32e-05	4.66e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.29e-05	4.61e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.25e-05	4.56e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.24e-05	4.53e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.22e-05	4.51e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	3.22e-05	4.51e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.21e-05	4.5e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.18e-05	4.46e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.17e-05	4.44e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	3.15e-05	4.41e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.13e-05	4.39e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.12e-05	4.37e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	3.12e-05	4.36e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.12e-05	4.36e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.01e-05	4.22e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.01e-05	4.22e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.01e-05	4.21e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.97e-05	4.16e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	2.97e-05	4.16e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2.94e-05	4.12e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.89e-05	4.05e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.89e-05	4.05e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.87e-05	4.02e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.87e-05	4.01e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.86e-05	4.01e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.86e-05	4e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.85e-05	4e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.84e-05	3.98e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.83e-05	3.96e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	2.81e-05	3.94e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.81e-05	3.94e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	2.78e-05	3.89e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	2.77e-05	3.87e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—INS—polycystic ovary syndrome	2.76e-05	3.87e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.75e-05	3.85e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	2.75e-05	3.85e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.73e-05	3.82e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.72e-05	3.81e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.72e-05	3.81e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.71e-05	3.8e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	2.71e-05	3.79e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.71e-05	3.79e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.7e-05	3.78e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.69e-05	3.77e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.66e-05	3.73e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.66e-05	3.72e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.65e-05	3.71e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.62e-05	3.67e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.62e-05	3.67e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.62e-05	3.66e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.59e-05	3.62e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.57e-05	3.59e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.53e-05	3.54e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.49e-05	3.48e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.44e-05	3.42e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.43e-05	3.4e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.41e-05	3.38e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.39e-05	3.35e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	2.38e-05	3.34e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	2.35e-05	3.29e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—INS—polycystic ovary syndrome	2.34e-05	3.27e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.31e-05	3.24e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.3e-05	3.23e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.29e-05	3.21e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.23e-05	3.13e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.19e-05	3.07e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.13e-05	2.98e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.1e-05	2.94e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.1e-05	2.94e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.09e-05	2.92e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.04e-05	2.86e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.03e-05	2.85e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2e-05	2.8e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.97e-05	2.76e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.96e-05	2.74e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.94e-05	2.72e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.93e-05	2.7e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.92e-05	2.69e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.91e-05	2.68e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.9e-05	2.66e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.87e-05	2.62e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.78e-05	2.5e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.74e-05	2.43e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.71e-05	2.39e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.69e-05	2.37e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.69e-05	2.36e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.66e-05	2.32e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.63e-05	2.29e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.63e-05	2.28e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.58e-05	2.21e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.36e-05	1.91e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.28e-05	1.79e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.26e-05	1.77e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.25e-05	1.76e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.2e-05	1.68e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.18e-05	1.66e-05	CbGpPWpGaD
